| Authors: |
Yu Y; Biostatistics Shared Resources, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Murphy MK; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Tan V; Department of Medicine, Oregon Health and Science University, Portland, Oregon, USA., Knight RJ; Cellular Therapy Laboratory, Hospital and Clinics, Oregon Health and Science University, Portland, Oregon, USA., Estalilla K; Cellular Therapy Laboratory, Hospital and Clinics, Oregon Health and Science University, Portland, Oregon, USA., Slater SE; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Kaempf A; Biostatistics Shared Resources, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Gandhi A; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Meyers G; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Cook RJ; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Maziarz RT; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA., Newell LF; Hematology and Medical Oncology, Knight Cancer Institute, Oregon Health and Science University, Portland, Oregon, USA. Electronic address: newelll@ohsu.edu. |
